title: Why we need to implement intramolecular hydrogen-bonding considerations in drug discovery.
authors.affiliation: Department of Molecular Biotechnology & Health Sciences, University of Torino, Via Quarello, 15, 10135-Torino, Italy.
authors.forename: Giulia
authors.initials: G
authors.lastname: Caron
authors.affiliation: Department of Molecular Biotechnology & Health Sciences, University of Torino, Via Quarello, 15, 10135-Torino, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Ermondi
mesh_terms: D055808:Drug Discovery; D006860:Hydrogen Bonding; D015394:Molecular Structure; D004364:Pharmaceutical Preparations / Q000737:chemistry*
chemical_list: D004364:Pharmaceutical Preparations
keywords: ADME-Tox; drug design; drug discovery; intramolecular hydrogen bond; intramolecular hydrogen bond propensity